These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 7055012)

  • 21. Therapeutic implications of central and peripheral neurologic mechanisms in migraine.
    Waeber C; Moskowitz MA
    Neurology; 2003 Oct; 61(8 Suppl 4):S9-20. PubMed ID: 14581653
    [No Abstract]   [Full Text] [Related]  

  • 22. Evaluation of drugs applicable to treatment of migraine in the cranial circulation of the monkey.
    Lance JW; Spira PJ; Mylecharane EJ; Lord GD; Duckworth JW
    Res Clin Stud Headache; 1978; 6():13-8. PubMed ID: 103151
    [No Abstract]   [Full Text] [Related]  

  • 23. The effects of humoral agents and antimigraine drugs on the cranial circulation of the monkey.
    Spira PJ; Mylecharane EJ; Lance JW
    Res Clin Stud Headache; 1976; 4():37-75. PubMed ID: 818690
    [No Abstract]   [Full Text] [Related]  

  • 24. Reflex vasomotor responses in the hands of migrainous subjects.
    French EB; Lassers BW; Desai MG
    J Neurol Neurosurg Psychiatry; 1967 Jun; 30(3):276-8. PubMed ID: 6033619
    [No Abstract]   [Full Text] [Related]  

  • 25. Drugs acting on 5-hydroxytryptamine receptors.
    Lancet; 1989 Sep; 2(8665):717-9. PubMed ID: 2570962
    [No Abstract]   [Full Text] [Related]  

  • 26. [Mechanism of action of drugs currently used in the prevention of migraine].
    Fanchamps A
    Minerva Med; 1976 Jun; 67(28):1858-60. PubMed ID: 59325
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of 5-hydroxytryptamine and ergotamine on human superficial temporal artery.
    Ostergaard JR; Mikkelsen E; Voldby B
    Cephalalgia; 1981 Dec; 1(4):223-8. PubMed ID: 7347625
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The treatment of migraine].
    Titus F
    Rev Neurol; 1997 Feb; 25(138):295-300. PubMed ID: 9147762
    [No Abstract]   [Full Text] [Related]  

  • 29. [Improper equalization of sumatriptan with ergotamine and dihydroergotamine in the Drug Equivalency System].
    Ferrari MD; Haan J; Bax WA; van Coevorden RS; Timmerman H; Meijler WJ
    Ned Tijdschr Geneeskd; 1993 Apr; 137(17):846-50. PubMed ID: 8387648
    [No Abstract]   [Full Text] [Related]  

  • 30. Role of some biogenic substances in migraine and relevant mechanism in antimigraine action of ergotamine--studies in an experimental model for migraine.
    Saxena PR; de Vlaam-Schluter GM
    Headache; 1974 Jan; 13(4):142-63. PubMed ID: 4149297
    [No Abstract]   [Full Text] [Related]  

  • 31. [Vasoneuroactive substance, antiaminic BC-105 and migraine].
    Sicuteri F; Anselmi B; Del Bianco PL
    Clin Ter; 1967 Jan; 40(2):117-28. PubMed ID: 4386485
    [No Abstract]   [Full Text] [Related]  

  • 32. Ergotamine and methysergide as serotonin partial agonists in migraine.
    Fanciullacci M; Granchi G; Sicuteri F
    Headache; 1976 Nov; 16(5):226-31. PubMed ID: 977328
    [No Abstract]   [Full Text] [Related]  

  • 33. [Etiology and treatment of migraine].
    Petelin LS; Shtok VN; Pigarev VA
    Sov Med; 1976 Nov; (11):62-5. PubMed ID: 1006395
    [No Abstract]   [Full Text] [Related]  

  • 34. Serotonin inhibits trigeminal nucleus activity evoked by craniovascular stimulation through a 5HT1B/1D receptor: a central action in migraine?
    Goadsby PJ; Hoskin KL
    Ann Neurol; 1998 Jun; 43(6):711-8. PubMed ID: 9629840
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serotonin receptors and the acute attack of migraine.
    Goadsby PJ
    Clin Neurosci; 1998; 5(1):18-23. PubMed ID: 9523053
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 5-Hydroxytryptamine receptor subtypes and the pharmacology of migraine.
    Peroutka SJ
    Neurology; 1993 Jun; 43(6 Suppl 3):S34-8. PubMed ID: 8389009
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [5-Hydroxytryptamine and physiopathology of pain; on a polyalgic syndrome in the course of therapy with para-chlorophenylalanine].
    Sicuteri F; Anselmi B; Franchi G; Fanciullacci M; Del Bianco PL
    Clin Ter; 1972 Jun; 61(6):491-501. PubMed ID: 4273807
    [No Abstract]   [Full Text] [Related]  

  • 38. [Aggregation and 3H-serotonin release from thrombocytes stimulated by serotonin in patients with migraine].
    Pukhal'skaia TG; Kolosova OA; Men'shikov MIu
    Biull Eksp Biol Med; 1998 Aug; 126(8):156-9. PubMed ID: 9777225
    [No Abstract]   [Full Text] [Related]  

  • 39. Drug treatment of migraine headache.
    Calesnick B
    Am Fam Physician; 1982 May; 25(5):228-30. PubMed ID: 7072580
    [No Abstract]   [Full Text] [Related]  

  • 40. 5-HT receptors mediating external carotid vasoconstriction in vagosympathectomized dogs.
    Villalón CM; Centurión D; Sánchez-López A; De Vries P; Saxena P
    Zhongguo Yao Li Xue Bao; 1999 Dec; 20(12):1057-67. PubMed ID: 11216445
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.